产品编号 | 产品名称 | CAS No. |
DC26114 |
GpTx-1
GpTx-1 is a potent, selective, 34-residue peptide antagonist of Nav1.7 sodium channel with IC50 of 10 nM, displays 20- and 1000- fold selectivity over NaV1.4 and NaV1.5.. |
1661050-12-9 |
DC26116 |
Poloppin
Poloppin is a cell-active, small molecule inhibitor of protein-protein interaction via the Polo-box domain (PBD) of the mitotic Polo-like kinase (PLK) with IC50 of 26.9 uM (PLK1) in FP assays. |
683808-78-8 |
DC26139 |
2-(5-Chloro-1H-indol-2-yl)acetic acid
2-(5-Chloro-1H-indol-2-yl)acetic acid|CAS 720000-48-6 |
720000-48-6 |
DC26151 |
Naloxone (hydrochloride)
Naloxone is an opioid inverse agonist drug used to counter the effects of opiate overdose. |
357-08-4 |
DC26155 |
Sulfaphenazole
Sulfaphenazole is an inhibitor of CYP2C9 (Ki = 0.3 μM) that demonstrates at least 100-fold selectivity over other CYP450 isoforms (Kis = 63 and 29 μM for CYP2C8 and CYP2C18, respectively, and no activity at CYP1A1, CYP1A2, CYP3A4, CYP2C19). |
526-08-9 |
DC26160 |
Ethosalamide
Etosalamide, also known as Ethosalamide, is an antipyretic and analgesics agent. |
15302-15-5 |
DC26173 |
YM-53601
YM-53601 is a squalene synthase inhibitor (IC50s = 79 and 90 nM in HepG2 cells and rat liver microsomes, respectively). |
182959-33-7 |
DC26175 |
NLX-101(F-15599)
NLX-101(F-15599) is a novel compound that activates serotonin 5-HT1A receptors with exceptional selectivity, having over 1000-fold higher affinity for this target over other receptors. |
635323-95-4 |
DC26189 |
TVB-2640
TVB-2640 is an orally bioavailable fatty acid synthase (FASN) inhibitor, with potential antineoplastic activity. |
1399177-37-7 |
DC28714 |
FK962
FK962 is an enhancer of somatostatin release, exerts cognitive-enhancing actions. Anti-dementia properties. |
283167-06-6 |
DC7229 |
PF-4708671
PF-4708671 is a novel cell-permeable inhibitor of S6K1 (p70 ribosomal S6 kinase 1), with a Ki of 20 nM and IC50 of 160 nM. |
1255517-76-0 |
DC7773 |
BNC-105
BNC105 is a novel tubulin polymerization inhibitor that selectively disrupts tumor vasculature and displays single-agent antitumor efficacy. |
945771-74-4 |
DC7992 |
PX 12
PX-12(IV-2) is an irreversible inhibitor of Thioredoxin-1(Trx-1) currently in clinical development as an antitumor agent; IC50=7 uM in Hela, MTT assay, 72 h. |
141400-58-0 |
DC8729 |
Bifeprunox
Bifeprunox is a Dopamine D2 and 5-HT1A partial agonist in development as a potential treatment for schizophrenia and other psychotic indications. |
350992-10-8 |
DC8983 |
Ibudilast
Ibudilast(KC-404;AV-411;MN-166) is a relatively nonselective phosphodiesterase inhibitor which has been marketed for treating asthma,ibudilast (MN-166) is tested to treat acute respiratory distress syndrome (ARDS) associated with Covid-19. |
50847-11-5 |
DC9619 |
Nafamostat (mesylate)
Nafamostat mesylate, a synthetic serine protease inhibitor, is an anticoagulant,showed highly potent activity against COVID-19(SARS-COV-2). |
82956-11-4 |
DC9743 |
CB1954(Tretazicar)
CB1954(Tretazicar) in stock,price: 350 USD/100mg. CB1954(Tretazicar) is a anticancer prodrug that is converted in the presence of the enzyme NQO2 and co-substrate caricotamide ( EP-0152R) (EP) into a potent cytotoxic bifunctional alkylating agent.It can |
21919-05-1 |
DCAPI1085 |
Clevudine (Levovir)
Clevudine (Levovir) is an antiviral drug for the treatment of hepatitis B,showed potent activity against COVID-19(SARS-COV-2) . |
163252-36-6 |
DCAPI1165 |
Ribavirin (Copegus)
Ribavirin is a guanosine analog with antiviral properties against DNA and RNA viruses, including respiratory syncytial virus, hepatitis C, and influenza. |
36791-04-5 |
DCAPI1390 |
Atovaquone (Atavaquone)
Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia. |
95233-18-4 |
DC8759 |
Thiamet G
Thiamet G is a potent and selective inhibitor of O-GlcNAcase that demonstrates a Ki value of 21 nM. |
1009816-48-1 |
DC10134 |
Obicetrapib (AMG-899,TA-8995)
Obicetrapib is a CETP inhibitor, on the elevation of high-density lipoprotein cholesterol (HDL-C) and reduction of low-density lipoprotein cholesterol (LDL-C), alone and in combination with statin therapy. |
866399-87-3 |